Antibody–Prodrug Conjugates with KSP Inhibitors and Legumain-Mediated Metabolite Formation

Abstract

Invited for the cover of this issue is the group of Hans-Georg Lerchen and colleagues from Bayer AG R&D Pharmaceuticals. The image, provided by J. Franz and graphic designers from The New Atlantic (Cologne), depicts a cartoon representation of the legumain-mediated cleavage of the peptide cap within the lysosome. Read the full text of the article at 10.1002/chem.201900441.